Hamilton Lane (NASDAQ:HLNE) Azioni

Hamilton Lane

Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.

Hamilton Lane Incorporated - Class A Common Stock

Hamilton Lane Inc

Sagtec Global Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGT#NASDAQ">SAGT</a>) ("Sagtec" or the "Company"), a next-generation provider of customizable AI, robotics, and automation platforms, today issued financial guidance for the fiscal year ending December 31, 2025. The Company is forecasting FY2025 revenue of approximately US$22.3 million, a 92% year-over-year increase compared to US$11.6 million in FY2024.

News

Guidance

SAGT

Sagtec Global Expects FY25 Revenue Of ~$22.3M Vs $11.6M In FY2024, Up 92% YoY

Macro Economic Events

Econ #s

Economics

Core PPI (YoY) (May) +3% vs +3.1% Est.

Macro Notification

General

USA Initial Jobless Claims 248K Vs 242K Est.

USA PPI (MoM) For May 0.1% Vs 0.2% Est.

US PPI (YoY) (May) +2.6% vs +2.6% Est.

U.S.-listed Chinese stocks Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>),&nbsp;Baidu, Inc. (NASDAQ: BIDU),&nbsp;JD.Com, Inc. (NASDAQ: JD),&nbsp;and&nbsp;PDD Holdings Inc. (NASDAQ: PDD)&nbsp;are trading lower on Thursday as President&nbsp;Donald Trump confirmed a <a target="_blank" href="https://www.benzinga.com/news/25/06/45882971/wall-street-eyes-record-highs-as-trump-seals-china-deal-soft-inflation-eases-tariff-jitters" rel="noreferrer noopener">China trade deal</a> after two days of negotiations in London.
It is worth noting that the tariffs are in place despite fresh inflation data coming in softer&nbsp;than expected for May.
The U.S. will continue applying 55% tariffs on selected Chinese imports, while China will impose a 10% tariff rate on U.S. goods.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/06/45729089/china-stocks-get-boost-as-ubs-hsbc-cite-stimulus-hopes-tariff-truce-cheap-valuations" rel="noreferrer noopener">China Stocks Get Boost As UBS, HSBC Cite Stimulus Hopes, Tariff Truce, Low Valuations</a>
Chinese EV stocks, including&nbsp;Nio Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), Li Auto Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), and XPeng Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>), are also trading lower.
U.S. and Chinese officials met in London on Monday for trade talks, which, according to reports, likely focused on rare earth minerals.
<a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/06/45841817/us-listed-chinese-stocks-gain-as-us-china-trade-talks-spark-optimism" rel="noreferrer noopener">The meeting came</a> after Trump and Chinese President Xi Jinping discussed trade issues on the phone&nbsp;last week.
China has reportedly&nbsp;granted temporary approvals&nbsp;for the export of rare earths, while jetliner&nbsp;Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) has&nbsp;begun commercial jet deliveries&nbsp;in China.
Rare earth elements play significant roles, from smartphones to electric vehicles to fighter jets. The U.S. depends on China for ~70% of imports of rare earth elements, signaling U.S. supply chain risks, SCMP&nbsp;<a target="_blank" href="https://www.scmp.com/economy/global-economy/article/3313697/ahead-us-china-talks-chinas-rare-earth-trade-data-may-shows-leverage-action" rel="noreferrer noopener">reported</a> on Monday, citing analyst estimates.
<h2 class="wp-block-heading">PDD Holding Stock Prediction For 2025</h2>
Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of PDD Holdings have an average 1-year price target of $132.7, representing an expected upside of 28.64%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. No analysts have bearish recommendations on PDD Holdings, while 5 analysts have bullish ratings. The street high price target from Citigroup is $165.0, while the street low from JP Morgan is $105.0.
Price Action: BABA shares are trading lower by 2.67%, BIDU by 0.25%, XPEV by 2.55% and NIO by 1.60%, PDD down 1.60% in the premarket session at the last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45840001/apples-wwdc-analyst-sees-ai-unveil-siri-revamp-and-alibaba-deal-as-catalyst-for-iphone-upgrade" target="_blank" rel="noreferrer noopener">Apple&#8217;s WWDC: Analyst Sees AI Unveil, Siri Revamp And Alibaba Deal As Catalyst For iPhone Upgrade</a></li>
</ul>
Photo via Shutterstock

Movers

Media

BABA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

XPEV

US Listed Chinese Tech And EV Stocks Slide As Trump Confirms China Trade Deal

Needham analyst Gil Blum reiterates Fate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>) from Hold to Hold.

Reiteration

Analyst Ratings

FATE

Needham Reiterates Hold on Fate Therapeuticsto Hold

<a href="https://www.globenewswire.com/Tracker?data=63kUTdvgMrLIKQ-oU7LLmP3BAN0y5HH2Yk9j6PTCa3_2-z8ezKwLTP-HS5ernlQ3FitgnXapefoNhkKQD4eGP_R9aIB-E65xLs0UAs_VAW-XaQVP1jR_q5gQpdaieC8A">ReShape Lifesciences</a>&#xAE; (NASDAQ:<a href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive U.S. distribution agreement with Recon Supply. Through this new strategic partnership, Recon Supply will distribute ReShape's cutting-edge portfolio, including the STIMEL-03 neuromuscular rehabilitation device, the next-generation Lap-Band&#xAE; 2.0 FLEX, and the full range of ReShape products, across the Veterans Administration (VA) and Department of Defense (DoD) healthcare systems. This collaboration will expand access to proven, life-changing treatments for more than 18 million U.S. veterans and active military personnel.

RSLS

ReShape Lifesciences Signs U.S. Distribution Agreement With Recon Supply To Distribute ReShape's Cutting-Edge Portfolio Across VA And DoD Healthcare Systems

Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) reported better-than-expected fourth-quarter financial results and issued <a href="https://www.benzinga.com/quote/ORCL/earnings">upbeat outlook commentary on Wednesday.</a>
The company reported fourth-quarter revenue of $15.9 billion, beating analyst estimates of $15.58 billion. The company reported fourth-quarter adjusted earnings of $1.70 per share, beating analyst estimates of $1.64 per share, according to Benzinga Pro.
"FY25 was a very good year — but we believe FY26 will be even better as our revenue growth rates will be dramatically higher," said Safra Catz, CEO of Oracle. "We expect our total cloud growth rate — applications plus infrastructure — will increase from 24% in FY25 to over 40% in FY26. Cloud Infrastructure growth rate is expected to increase from 50% in FY25 to over 70% in FY26. And RPO is likely to grow more than 100% in FY26."
Oracle's board declared a quarterly cash dividend of 50 cents per share, payable on July 24 to shareholders of record as of July 10.
Oracle's shares fell 0.6% to close at $176.38 on Wednesday.
These analysts made changes to their price targets on Oracle following earnings announcement.
<ul class="wp-block-list">
<li>Piper Sandler analyst Brent Bracelin maintained Oracle with a Neutral and raised the price target from $130 to $190.</li>
<li>WestPark Capital analyst Curtis Shauger maintained the stock with a Buy and boosted the price target from $195 to $246.</li>
</ul>
Considering buying ORCL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/ORCL/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192-1024x584.png" alt="" class="wp-image-947574" style="width:712px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192.png 1092w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45882911/top-2-consumer-stocks-that-may-plunge-in-june">Top 2 Consumer Stocks That May Plunge In June</a> </li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Pre-Market Outlook

Markets

Trading Ideas

ORCL

These Analysts Increase Their Forecasts On Oracle Following Upbeat Q4 Earnings

WIIM

NEHC

New Era Helium shares are trading higher after the company announced that its joint venture with Sharon AI, Texas Critical Data Centers, is in active discussions with enterprises to anchor its planned AI infrastructure buildout in Texas.

Maxim Group analyst Jack Vander Aarde upgrades Datavault AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVLT#NASDAQ">DVLT</a>) from Hold to Buy and announces $3 price target.

Upgrades

DVLT

Maxim Group Upgrades Datavault AI to Buy, Announces $3 Price Target

Oxford Industries shares are trading lower after the company reported Q1 financial results and issued Q2 adjusted EPS guidance below estimates. Also, the company lowered its FY25 guidance.

HUB Cyber Security Ltd. (NASDAQ: HUBC) ("HUB" or the "Company"), a global leader in confidential computing and advanced secured data fabric technology, today announced that it is in full compliance with all applicable listing requirements of the Nasdaq Capital Market.
Nasdaq has formally confirmed that HUB satisfies both the minimum bid price and the market value of listed securities (MVLS) thresholds under Listing Rules 5550(a)(5) and 5550(b)(2), the "Bid Price" and "MVLS Rules," respectively. This milestone follows a period of strategic restructuring, improved financial execution, and strengthened corporate governance. Moreover, the Nasdaq Hearings Panel (the "Panel") has confirmed that HUB has met all exceptions in the Panel's decision in achieving compliance with the Nasdaq Bid Price and MVLS Rules listing standards.

HUBC

HUB Cyber Security Says It Is In Full Compliance With All Applicable Listing Requirements Of Nasdaq Capital Market

Chimera Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) announced Thursday it will acquire HomeXpress Mortgage Corp., a non-QM and non-agency loan originator with a nationwide footprint <a href="https://www.benzinga.com/pressreleases/25/06/b45900081/chimera-investment-corporation-nyse-cim-chimera-announces-definitive-agreement-to-acquire-homexpre">spanning 46 states and Washington, D.C</a>.
The deal, signed on June 11, includes a payment of $120 million in cash and 2,077,151 shares of Chimera stock. It will be executed through Chimera's taxable REIT subsidiary, Chimera Funding TRS.
The acquisition will expand Chimera's access to mortgage loan origination and strengthen its securitization and servicing operations, aligning with its long-term growth strategy. The transaction is expected to close in the fourth quarter of 2025.
Also Read: <a href="https://www.benzinga.com/real-estate/25/06/45831855/gen-z-turns-to-siblings-and-side-hustles-to-afford-homes-amid-soaring-prices">Gen Z Turns To Siblings And Side Hustles To Afford Homes Amid Soaring Prices</a>
Chimera anticipates the deal will be earnings-accretive beginning in 2026. HomeXpress has operated profitably since its founding in 2016, generating $47 million in pre-tax income in 2024. 
The company originated $2.5 billion in loans last year and projects $3.5 billion in volume for 2025, supported by its strong broker and correspondent partner network.
Following the acquisition, HomeXpress will continue as a wholly owned subsidiary, with CEO Kyle Walker and his senior leadership team staying on to lead the business.
Chimera also plans to leverage existing net operating losses to offset the acquisition premium. It will gain additional revenue streams through origination fees and gain-on-sale income, helping diversify its earnings base.
CIM held cash and cash equivalents of <a href="https://www.benzinga.com/pressreleases/25/05/b45280351/chimera-investment-corporation-reports-1st-quarter-2025-earnings" target="_blank" rel="noreferrer noopener">$253.349 million</a> as of March 31, 2025.
Other companies involved in the residential and mortgage sector include PennyMac Financial Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFSI#NYSE">PFSI</a>) and Rocket Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>).
Investors may also watch mortgage-focused ETFs, such as the iShares MBS ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBB#NASDAQ">MBB</a>) and the VanEck Mortgage REIT Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MORT#NYSE">MORT</a>).
Price Action: CIM shares are trading lower by 0.22% to $13.89 premarket at last check Thursday.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/45900930/gold-surpasses-euro-to-become-second-largest-reserve-asset-still-far-behind-dollar-ecb-says" target="_blank" rel="noreferrer noopener">Gold Surpasses Euro To Become Second-Largest Reserve Asset, Still Far Behind Dollar, ECB Says</a></li>
</ul>
Photo by Gumbariya via Shutterstock

MORT

PFSI

Chimera Expands Mortgage Reach With HomeXpress Acquisition

Yiren Digital shares are trading lower after the company reported a year-over-year decrease in Q1 EPS results.

Lake Street analyst Frank Takkinen assumes Beta Bionics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBNX#NASDAQ">BBNX</a>) with a Buy rating and announces Price Target of $30.

Initiation

BBNX

Lake Street Assumes Beta Bionics at Buy, Announces Price Target of $30

DFDV

DeFi Development shares are trading lower. The company announced it secured a $5 billion equity facility with RK Capital.

Needham analyst Bernie McTernan maintains Genius Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) with a Buy and maintains $13 price target.

GENI

Needham Maintains Buy on Genius Sports, Maintains $13 Price Target

Inuvo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INUV#NYSE">INUV</a>), a leading provider of artificial intelligence-driven AdTech solutions, today announced that it was reaffirming its prior guidance that the Company was expecting revenue growth for the second quarter of not less than 25% on a year-over-year basis. The Company also completed a 1-for-10 reverse stock split of its outstanding common stock, as approved by shareholders at the Annual Meeting held on May 22, 2025.

Stock Split

INUV

Inuvo Reaffirms Q2 Revenue Growth Guidance Of Not Less Than 25% YoY; Completes 1:10 Reverse Stock Split

CVGW

Calavo Growers shares are trading higher after the company announced it received a non-binding proposed to acquire shares at 32.00 per share.

Press Releases

2025 Hamilton Lane Market Overview: Private Markets Reach an Inflection Point, though Long-Term Fundamentals Remain Strong

Hamilton Lane Pioneers Access to Private Markets with the First U.S. Infrastructure Evergreen Fund Available to Retail Investors on Republic with a Minimum Initial Investment of $500

Real Estate

Hamilton Lane Partners with Dalan Real Estate to Acquire $74 million NYC Multifamily Portfolio

PAX Health Acquires Richardson Psychiatric Associates, Expanding Mental Health Services for Adults, Adolescents, and Families

Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

Mutual Funds

Offerings

Hamilton Lane Launches U.S. Venture Capital and Growth Evergreen Fund, Further Expanding its $10B+ AUM Evergreen Platform

Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Results on May 29, 2025

Financing

Classiq Raises $110M in Largest-Ever Quantum Software Funding Round

Dividends

HAMILTON LANE INCORPORATED REPORTS STRONG FOURTH FISCAL QUARTER AND FISCAL YEAR 2025 RESULTS, WITH MANAGEMENT AND ADVISORY FEES GROWING BY 14% AND ASSETS UNDER MANAGEMENT GROWING BY 11% YEAR-OVER-YEAR

Comments

Hamilton Lane

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO